Aperio Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $21.8M | Buy |
76,873
+7,939
| +12% | +$2.23M | 0.06% | 294 |
|
|
2020
Q3 | $18.9M | Buy |
68,934
+10,461
| +18% | +$2.77M | 0.06% | 281 |
|
|
2020
Q2 | $13.3M | Buy |
58,473
+9,646
| +20% | +$1.9M | 0.05% | 369 |
|
|
2020
Q1 | $7.43M | Buy |
48,827
+6,662
| +16% | +$1.03M | 0.03% | 514 |
|
|
2019
Q4 | $6.34M | Sell |
42,165
-1,795
| -4% | -$261K | 0.02% | 651 |
|
|
2019
Q3 | $6.24M | Sell |
43,960
-916
| -2% | -$126K | 0.02% | 633 |
|
|
2019
Q2 | $5.62M | Buy |
44,876
+955
| +2% | +$113K | 0.02% | 671 |
|
|
2019
Q1 | $4.84M | Sell |
43,921
-283
| -0.6% | -$29.4K | 0.02% | 714 |
|
|
2018
Q4 | $4.33M | Sell |
44,204
-106
| -0.2% | -$11.5K | 0.02% | 693 |
|
|
2018
Q3 | $5.47M | Sell |
44,310
-219
| -0.5% | -$24.6K | 0.02% | 649 |
|
|
2018
Q2 | $4.42M | Sell |
44,529
-460
| -1% | -$42.3K | 0.02% | 713 |
|
|
2018
Q1 | $3.97M | Buy |
44,989
+978
| +2% | +$91.5K | 0.02% | 738 |
|
|
2017
Q4 | $4.34M | Sell |
44,011
-354
| -0.8% | -$34.7K | 0.02% | 688 |
|
|
2017
Q3 | $4.27M | Sell |
44,365
-863
| -2% | -$78.1K | 0.02% | 659 |
|
|
2017
Q2 | $4.28M | Buy |
45,228
+14,632
| +48% | +$1.35M | 0.03% | 650 |
|
|
2017
Q1 | $2.5M | Buy |
30,596
+1,877
| +7% | +$157K | 0.02% | 795 |
|
|
2016
Q4 | $2.44M | Sell |
28,719
-1,516
| -5% | -$119K | 0.02% | 752 |
|
|
2016
Q3 | $2.25M | Buy |
30,235
+3,831
| +15% | +$304K | 0.02% | 798 |
|
|
2016
Q2 | $2M | Buy |
26,404
+896
| +4% | +$65.2K | 0.02% | 807 |
|
|
2016
Q1 | $1.77M | Buy |
25,508
+1,873
| +8% | +$113K | 0.02% | 825 |
|
|
2015
Q4 | $1.42M | Buy |
23,635
+729
| +3% | +$43.9K | 0.01% | 876 |
|
|
2015
Q3 | $1.24M | Sell |
22,906
-497
| -2% | -$29K | 0.01% | 895 |
|
|
2015
Q2 | $1.36M | Buy |
23,403
+803
| +4% | +$44.8K | 0.01% | 852 |
|
|
2015
Q1 | $1.36M | Buy |
22,600
+1,693
| +8% | +$90.2K | 0.02% | 827 |
|
|
2014
Q4 | $1.11M | Buy |
20,907
+4,442
| +27% | +$222K | 0.01% | 859 |
|
|
2014
Q3 | $737K | Sell |
16,465
-144
| -0.9% | -$6.12K | 0.01% | 972 |
|
|
2014
Q2 | $701K | Buy |
16,609
+4,424
| +36% | +$189K | 0.01% | 986 |
|
|
2014
Q1 | $537K | Buy |
+12,185
| New | +$574K | 0.01% | 1298 |
|
|
2013
Q4 | – | Sell |
-9,200
| Closed | -$431K | – | 1230 |
|
|
2013
Q3 | $379K | Buy |
9,200
+1,326
| +17% | +$50.6K | 0.01% | 1287 |
|
|
2013
Q2 | $277K | Buy |
+7,874
| New | +$259K | 0.01% | 1320 |
|
Other funds holding WST
Aperio Group's WST Position: Q4 2020 in Review
Aperio Group increased its West Pharmaceutical (WST) stake by 12% in Q4 2020, buying an estimated $2.23M and bringing the position to 76,873 shares worth $21.8M. The position accounts for 0.06% of the portfolio, ranked #294.
Aperio Group first reported a position in WST in Q2 2013 and has held it in 30 quarters since. 593 funds tracked by Wall St. Rank hold WST as of Q4 2020.
- Aperio Group held 76,873 shares of West Pharmaceutical worth $21.8M as of Q4 2020.
- Aperio Group bought 7,939 West Pharmaceutical shares in Q4 2020, an estimated $2.23M.
- West Pharmaceutical made up 0.06% of Aperio Group's portfolio in Q4 2020, its #294 holding.
- Aperio Group first reported a position in West Pharmaceutical in Q2 2013 and has held it in 30 quarters since.
- 593 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.